RUNIMOTAMAB: 20 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
20
Total FAERS Reports
3 (15.0%)
Deaths Reported
6
Hospitalizations
20
As Primary/Secondary Suspect
1
Life-Threatening
First Report: 20211129 · Latest Report: 20231019
What Are the Most Common RUNIMOTAMAB Side Effects?
#1 Most Reported
Cytokine release syndrome
17 reports (85.0%)
#2 Most Reported
Road traffic accident
1 reports (5.0%)
#3 Most Reported
Pyrexia
1 reports (5.0%)
All RUNIMOTAMAB Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Cytokine release syndrome | 17 | 85.0% | 2 | 4 |
Who Reports RUNIMOTAMAB Side Effects? Age & Gender Data
Gender: 83.3% female, 16.7% male. Average age: 55.6 years. Most reports from: ES. View detailed demographics →
Is RUNIMOTAMAB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2021 | 1 | 0 | 1 |
| 2022 | 9 | 2 | 5 |
| 2023 | 9 | 0 | 0 |
What Is RUNIMOTAMAB Used For?
| Indication | Reports |
|---|---|
| Breast cancer metastatic | 8 |
| Gastrooesophageal cancer | 5 |
| Metastatic neoplasm | 5 |
Official FDA Label for RUNIMOTAMAB
Official prescribing information from the FDA-approved drug label.